Amcor (ASX:AMC) Closes Berry Global Merger, Reports Q3 Results
Amcor (ASX:AMC) closes Berry Global merger ahead of schedule, reports Q3 and YTD financial results, and declares a dividend.
Tag: Mergers & Acquisitions
Duxton Farms (ASX:DBF) Announces Strategic Acquisitions and Asset Sales in Q3 FY2025
Duxton Farms (ASX:DBF) reports Q3 FY2025 activities, including strategic land acquisitions and significant asset sales to support growth and shareholder returns.
Mont Royal Resources (ASX:MRZ) Announces Merger with Commerce Resources
Mont Royal Resources (ASX:MRZ) merges with Commerce Resources to form a Canadian-focused critical metals company, enhancing its asset portfolio.
Patronus Resources (ASX: PTN) Enhances Mertondale Resource and Acquires Strategic Stakes
Patronus Resources (ASX: PTN) reports increased mineral resources and strategic investments in Q1 2025.
betr Entertainment Limited (ASX:BBT) Announces Equity Raising and PointsBet Acquisition Proposal
betr Entertainment Limited (ASX:BBT) raises A$130 million to fund the acquisition of PointsBet, targeting over A$40 million in annual cost synergies.
Donaco International Limited (ASX:DNA) Reports Q3 FY2025 Results and Announces Share Acquisition Scheme
Donaco International (ASX:DNA) announces Q3 FY2025 results and a share acquisition Scheme Implementation Deed to strengthen its cash position.
Hansen Technologies Ltd (ASX:HSN) Acquires Strategic Assets in Germany
Hansen Technologies (ASX:HSN) acquires strategic software assets in Germany for A$13.4m, enhancing its market position and growth strategy.
Capricorn Metals Ltd (ASX:CMM) Acquires Ninghan Gold Project
Capricorn Metals Ltd (ASX:CMM) acquires the Ninghan Gold Project, expanding its Mt Gibson tenure and enhancing gold exploration prospects.
Insignia Financial Ltd (ASX:IFL) Announces Q3 2025 Business Update
Insignia Financial Ltd (ASX:IFL) reports a 1.5% decline in FUMA for Q3 2025, while progressing strategic initiatives and achieving strong inflows in key channels.
Telix Pharmaceuticals Limited (ASX:TLX) Reports $186M Q1 Revenue
Telix Pharmaceuticals Limited (ASX:TLX) reports a 62% increase in Q1 2025 revenue, reaching $186M.